Gene therapy

In this June 20, 2019 photo, the Capitol is seen from the roof of the Canadian Embassy in Washington. Health care is on the agenda for Congress when lawmakers return, and it’s not another battle over the Obama-era Affordable Care Act. Instead of dealing with the uninsured, lawmakers are trying to bring down costs for people who already have coverage. (AP Photo/J. Scott Applewhite)
July 07, 2019 - 8:00 am
WASHINGTON (AP) — Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already have coverage. Returning from their Fourth of July recess,...
Read More
This photo provided by Novartis shows Zolgensma. The one-time gene therapy developed by Novartis, Zolgensma, will cost $2.125 million. It treats a rare condition called spinal muscular atrophy, or SMA, which strikes about 400 babies born in the U.S. each year. The therapy, given in a one-hour infusion, was approved for children under age 2 and will be available within two weeks. (Novartis via AP)
May 24, 2019 - 1:35 pm
U.S. regulators have approved the most expensive medicine ever, for a disorder that destroys a baby's muscle control and kills nearly all of those with the most common variant of the disease within a couple years. The treatment is priced at $2.125 million. Out-of-pocket costs for patients will vary...
Read More
February 25, 2019 - 3:58 pm
Stocks closed modestly higher Monday after shedding most of the gains from an early rally spurred by the Trump administration's decision to hold off on increasing tariffs on imported Chinese goods. Investors welcomed the move, which averted an escalation in the damaging trade war between the world'...
Read More
In this Oct. 10, 2018, photo, scientist He Jiankui speaks during an interview in Shenzhen in southern China's Guandong province. China's government on Thursday, Nov. 29, 2018, ordered a halt to work by a medical team that claimed to have helped make the world's first gene-edited babies. (AP Photo/Mark Schiefelbein)
December 02, 2018 - 7:12 pm
HONG KONG (AP) — Early last year, a little-known Chinese researcher turned up at an elite meeting in Berkeley, California, where scientists and ethicists were discussing a technology that had shaken the field to its core — an emerging tool for "editing" genes, the strings of DNA that form the...
Read More
September 04, 2018 - 12:34 pm
LISBON, Portugal (AP) — Researchers in the United States and Britain are sharing a 1 million-euro ($1.16 million) prize from a Portuguese scientific foundation for developing revolutionary gene therapy that has restored the sight of children. The Lisbon, Portugal-based Champalimaud Foundation's...
Read More
FILE - In this Monday, Nov. 13, 2017 file photo, a nurse practitioner prepares to start the first human gene editing treatment for Hunter syndrome, an inherited metabolic disease, at a hospital in Oakland, Calif. On Wednesday, Aug. 15, 2018, federal officials said that gene therapy is becoming an established form of medical care and carries no special risks that warrant special regulation, as they revised rules for vetting such experiments and products. (AP Photo/Eric Risberg)
August 15, 2018 - 5:55 pm
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks. A special National Institutes of Health oversight panel will no longer review all...
Read More